DUROLANE is next generation hyaluronic acid treatment, based upon stabilised hyaluronic acid produced without using any animal-sourced materials (NASHA). DUROLANE has s longer residence time in the synovial joint compared to other stabilized and unstabilized HA products. . DUROLANE is a single injection treatment while other treatments need 3-5 injection course.
Monovisca is a sterile, non-pyrogenic, viscoelastic solution of hyaluronan contained in a single-use syringe. Monovisca consists of high molecular weight, ultra-pure, natural hyaluronan, a complex sugar of the glycosaminoglycan family. The hyaluronan in Monovisca is derived from bacterial cells and is cross-linked with a proprietary cross-linker.